+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Experimental formulations of Bacillus sphaericus for the control of anopheline and culicine larvae

Experimental formulations of Bacillus sphaericus for the control of anopheline and culicine larvae

Journal of Industrial Microbiology 3(1): 39-47

Four experimental formulations of B. sphaericus (2362 isolate) were evaluated for activity against mosquito larvae in several natural and artificial habitats. A granular formulation (5% primary powder) was tested against natural populations of mosquitoes in 2 simulated habitats in Florida and in rice fields in Louisiana.

(PDF emailed within 1 workday: $29.90)

Accession: 001831746

Download citation: RISBibTeXText

Related references

A field study of Bacillus sphaericus for the control of culicine and anopheline mosquito larvae in Tanzania. Bulletin of the Society for Vector Ecology 17(1): 45-50, 1992

Small scale field trials of Bacillus sphaericus (strain 2362) against anopheline and culicine mosquito larvae in southern Mexico. Journal of the American Mosquito Control Association 6(2): 300-305, 1990

Larvicidal activity of new isolates of bacillus sphaericus and bacillus thuringiensis h 14 against anopheline and culicine mosquitoes. Mosquito News 42(4): 537-543, 1982

Efficacy and longevity of Bacillus sphaericus 2362 formulations for control of mosquito larvae in dairy wastewater lagoons. Journal of the American Mosquito Control Association 4(4): 448-452, 1988

Sustained release formulations of Bacillus sphaericus (ISPC-5 = WHO-2173) for the control of mosquito larvae of Culex fatigans. Current Science, India 57(10): 530-532, 1988

Sustained release formulations of bacillus sphaericus ispc 5 equals who 2173 for the control of mosquito larvae of culex fatigans. Current Science (Bangalore) 57(10): 530-532, 1988

Small scale field trials with Bacillus thuringiensis variety israelensis H-14 strain against larvae of anopheline and culicine mosquitoes. Journal of Communicable Diseases 15(4): 223-234, 1983

Larvicidal activity of various formulations of bacillus thuringiensis h 14 and bacillus sphaericus 2362 against larvae of culex quinquefasciatus. Journal of Biological Sciences Research 18(3): 17-24, 1987

Simulated field studies with three formulations of bacillus thuringiensis var israelensis and bacillus sphaericus against larvae of mansonia bonneae diptera culicidae in sarawak malaysia. Bulletin of Entomological Research 80(2): 195-202, 1990

Field trials with Bacillus sphaericus and Bacillus thuringiensis serovar. israelensis commercial formulations against Culex quinquefasciatus larvae in suburban Dhaka, Bangladesh. Medical Entomology and Zoology 51(4): 257-264, 2000

Pathogenicity of industrial formulations of bacillus thuringiensis serovar israelensis to larvae of some culicine mosquitoes in the laboratory. Florida Entomologist 67(2): 193-197, 1984

Efficacy of two flowable formulations of Bacillus sphaericus against larvae of mosquitoes. Indian Journal of Malariology 32(2): 76-84, 1995

Larval anopheline mosquito recta exhibit a dramatic change in localization patterns of ion transport proteins in response to shifting salinity: a comparison between anopheline and culicine larvae. Journal of Experimental Biology 211(Pt 19): 3067-3076, 2008

Field trials with tank mixtures of Bacillus thuringiensis subsp. israelensis and Bacillus sphaericus formulations against Culex pipiens larvae in septic tanks in Antalya, Turkey. Journal of the American Mosquito Control Association 23(2): 161-165, 2007